TACTILE SYSTEMS TECHNOLOGY INC
Tactile Systems Technology, Inc. (TCMD) designs and markets pneumatic compression systems used to treat lymphoedema, chronic oedema and related circulatory conditions. Its business combines one-off device sales with recurring consumable garments, rentals and service contracts, creating a mix of upfront and recurring revenue. The company is a small‑cap medical device player (market cap ~ $329M) that relies on clinical adoption, reimbursement from insurers and distribution relationships to grow volumes. Key investor considerations include revenue growth and margin trends, cash flow and capital allocation, the pace of clinical evidence and payer coverage decisions. Competitive pressure, regulatory oversight and changes to reimbursement can materially affect outcomes, and small‑cap stocks can be volatile. This summary is educational only and not investment advice; investors should review the company’s SEC filings and consider their own risk tolerance and diversification needs before acting.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Tactile Systems' stock, believing it could rise from its current price.
Financial Health
Tactile Systems Technology is performing well with strong revenues and cash flow, indicating solid financial health.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Discover More Opportunities
Abbott
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
AGILENT TECHNOLOGIES INC
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. The Life Sciences and Diagnostics Markets segment provides contract development and manufacturing services for pharmaceutical customers as well as solutions that include reagents, instruments, software and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab segment spans the entire lab with its services and consumables portfolio in addition to software and laboratory automation solutions, which are designed to improve customer outcomes and represent a range of offerings designed to serve customer needs across end-markets and applications.
ALIGN TECHNOLOGY INC
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
Baskets Featuring TCMD
Injectable Drug Innovation Opportunities 2025
The FDA's approval of an at-home injectable version of Eisai and Biogen's Alzheimer's drug, Leqembi, simplifies treatment for patients and caregivers. This development highlights a growing trend toward patient-centric care, creating investment opportunities in companies that specialize in innovative drug delivery systems and at-home therapeutic technologies.
Published: August 31, 2025
Explore BasketWearable Tech IP Wars: What Investors Should Know
Masimo's lawsuit against U.S. Customs, following a reversal of an import ban on Apple Watches, highlights the fierce competition over intellectual property in wearable health. This theme focuses on the medical technology companies and competitors poised to benefit from the ongoing patent battles in the lucrative health-monitoring device market.
Published: August 21, 2025
Explore BasketHealthcare's Compliance Catalyst
The Department of Justice's investigation into UnitedHealth's billing practices is increasing pressure on the entire healthcare industry to ensure compliance. This regulatory focus creates an investment opportunity in companies that provide specialized technology for transparent and accurate medical billing.
Published: July 26, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Device + Consumables
The business blends one‑off device sales with recurring consumables and services, which can support revenue predictability—though uptake and reimbursement can vary.
Clinical Evidence Matters
Adoption by clinicians and payers often depends on clinical outcomes; positive studies can help growth, but results and timelines are uncertain.
Reimbursement & Regulation
Coverage decisions by Medicare and insurers materially affect volumes; regulatory or reimbursement shifts can quickly change the commercial outlook.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.